Bupivacaine Hydrochloride And Epinephrine Injection, Solution
Product Images NDC 0409-9045

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride And Epinephrine (NDC 0409-9045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Bupivacaine 01)

Chemical structure of bupivacaine hydrochloride, depicting its molecular composition including a piperidine ring, an amide linkage, a substituted aromatic ring with two methyl groups, and associated hydrochloride and water molecules.*

FDA Label Image

Structural Formula Bupivacaine Hydrochloride (Bupivacaine 02)

Chemical structure diagram showing a molecule with a benzene ring bonded to three hydroxyl groups and an adjacent carbon connected to a hydroxyl group and an amine group. The structure is related to the active ingredient Bupivacaine Hydrochloride.*

FDA Label Image

Structural Formula Epinephrine (Bupivacaine 03)

FDA Label Image

Hospira Logo (Bupivacaine 04)

Label for Bupivacaine HCl 0.25% (2.5 mg/mL) and epinephrine 1:200,000 injection in a 50 mL multiple-dose fliptop vial by Hospira, Inc. The label includes concentration, warnings about sulfites and nervous system effects, storage instructions, lot number and expiration placeholders, and barcoded NDC 0409-9043-11.*

FDA Label Image

Principal Display Panel (100 mg/20 mL Ampul Container Label)

Packaging label for Bupivacaine Hydrochloride 2.5 mg/mL and epinephrine 1:200,000 injection, USP. This 50 mL multiple-dose fliptop vial by Hospira, Inc. contains sterile, nonpyrogenic solution. The label includes warnings about sulfites and instructions to protect the product from light and avoid autoclaving. Storage conditions and usage precautions are also noted.*

FDA Label Image

Carton Ndc 0409-4273-01 (Bupivacaine 06)

Label for Bupivacaine Hydrochloride 0.5% (5 mg/mL) and epinephrine 1:200,000 injection in a 10 mL single-dose teartop vial. The label states that it is for nerve block, caudal, and epidural anesthesia only. It includes caution about sulfites and detailed composition with epinephrine and preservatives. The product is labeled as Rx only and distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Label)

BUPIVACAINE HYDROCHLORIDE 0.5% (5 mg/mL) and epinephrine 1:200,000 Injection in a 10 mL single-dose teartop vial. Label indicates sterile, nonpyrogenic product for nerve block, caudal, and epidural anesthesia only. Contains sulfites and is distributed by Hospira, Inc. Barcode, lot, serial number, and expiration placeholders are present.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Carton)

Label for Bupivacaine Hydrochloride 0.5% (5 mg/mL) with Epinephrine 1:200,000 Injection in a 50 mL multiple-dose vial. The label includes dosing and storage information, warnings including sulfite content, and the distributor Hospira, Inc., Lake Forest, IL. It notes the product is for nerve block only and Rx only.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Label)

Packaging label for Bupivacaine Hydrochloride and Epinephrine Injection, USP 0.5% (5 mg/mL), 250 mg/50 mL in a 50 mL multiple-dose fliptop vial. Distributed by Hospira, Inc. The label states it is sterile, nonpyrogenic, and highlights that it is for nerve block only, not for caudal, epidural, or spinal anesthesia. It includes storage instructions and warnings about sulfites.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Carton)

BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL (25 mg/10 mL) injection vial label from Hospira, Inc. It is a 10 mL single-dose teartop vial of 0.25% Bupivacaine HCl with epinephrine 1:200,000. The label includes dosage and storage instructions, a barcode, lot and expiration date placeholders, and warnings including sulfite content.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Label)

Label for Bupivacaine Hydrochloride and Epinephrine Injection, USP, 0.25% Bupivacaine Hydrochloride (2.5 mg/mL) and epinephrine 1:200,000, in a 10 mL single-dose teartop vial. The label indicates its use for infiltration, nerve block, caudal, and epidural anesthesia and is distributed by Hospira, Inc. It includes warnings about sulfites and instructions for aseptic technique.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Carton)

Label for Bupivacaine Hydrochloride Injection USP 0.25% (2.5 mg/mL) in a 10 mL single-dose teartop vial by Hospira, Inc. The label states it is preservative-free and contains 25 mg/10 mL. It is indicated for infiltration, nerve block, caudal, and epidural anesthesia, with a warning that it is not for spinal anesthesia. Additional information includes dosage, storage instructions, and distributor details.*

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Label)

Packaging label for Bupivacaine Hydrochloride Injection, USP 0.25% (2.5 mg/mL) in a 10 mL single-dose teartop vial. The label indicates it is preservative-free, for infiltration, nerve block, caudal and epidural anesthesia, and not for spinal anesthesia. Manufactured by Hospira, Inc., the label includes NDC 0409-1159-01 and storage instructions.*

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Carton)

Label for Bupivacaine Hydrochloride Injection USP 0.25%, 75 mg/30 mL (2.5 mg/mL) single-dose teartop vial by Hospira, Inc. The label indicates it is preservative-free and intended for infiltration, nerve block, caudal, and epidural anesthesia, with a warning stating it is not for spinal anesthesia. The vial size is 30 mL.*

FDA Label Image

Principal Display Panel (75 mg/30 mL Ampul Label)

Label for Bupivacaine Hydrochloride Injection, USP 0.25% (2.5 mg/mL), 75 mg/30 mL in a 30 mL single-dose teartop vial. The preservative-free product is labeled for use in infiltration, nerve block, caudal, and epidural anesthesia but not for spinal anesthesia. Manufactured by Hospira, Inc., the label displays NDC 0409-1159-02 and specifies storage conditions.*

FDA Label Image

Principal Display Panel (75 mg/30 mL Ampul Carton)

Label for Bupivacaine Hydrochloride Injection, USP 0.25% (2.5 mg/mL) in a 50 mL multiple-dose fliptop vial. The label states the strength as 125 mg/50 mL, highlights use for infiltration and nerve block, and includes warnings against caudal, epidural, or spinal anesthesia. Distributed by Hospira, Inc. The label also shows the NDC code, barcode, and storage instructions.*

FDA Label Image

Principal Display Panel (150 mg/30mL Ampul Label)

Label for Bupivacaine Hydrochloride Injection USP, 0.25% strength (2.5 mg/mL) in a 50 mL multiple-dose fliptop vial. The label includes dosing information as 125 mg per 50 mL, highlights use for infiltration and nerve block, and includes a warning against caudal, epidural, or spinal anesthesia. The labeler is Hospira, Inc. The label also states the product is made in Switzerland and distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (150 mg/30 mL Ampul Carton)

Label for 0.5% Bupivacaine Hydrochloride Injection, USP 50 mg/10 mL (5 mg/mL) preservative-free solution in a 10 mL single-dose teartop vial. The label specifies use for nerve block, caudal and epidural anesthesia, and states it is not for spinal anesthesia. Distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Label-1159)

Bupivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) in a 10 mL single-dose teardrop vial carton. Label indicates preservative-free formulation, with a total strength of 50 mg per 10 mL. Manufactured by Hospira, Inc., with NDC 0409-1162-01. The label includes usage instructions specifying it is for nerve block, caudal, and epidural anesthesia but not for spinal anesthesia.*

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Tray)

Label for Bupivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL), 150 mg/30 mL single-dose teartop vial by Hospira, Inc. Contains 5 mg/mL bupivacaine HCl with sodium chloride and possible pH adjusters. Intended for nerve block, caudal, and epidural anesthesia; not for spinal anesthesia. Rx only with storage instructions included.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Label)

Label for Bupivacaine Hydrochloride Injection USP, 0.5% (5 mg/mL) strength in a 30 mL single-dose teartop vial. The label states it is preservative-free and contains 150 mg per 30 mL vial. The labeler is Hospira, Inc., and the product is indicated for nerve block, caudal, and epidural anesthesia with a caution that it is not for spinal anesthesia. The label includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Tray)

Label for Bupivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL), 250 mg per 50 mL multiple-dose fliptop vial by Hospira, Inc. The label states it is for nerve block use and specifically notes it is not for caudal, epidural, or spinal anesthesia. The label also includes storage information, dosage instructions reference, and NDC 0409-1163.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Label)

Carton label for Bupivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) in a 50 mL multiple-dose fliptop vial. The label indicates a total of 250 mg per 50 mL vial. The product is labeled for nerve block use and specifically states it is not for caudal, epidural, or spinal anesthesia. The labeler is Hospira, Inc., and the product is made in Switzerland and distributed in the USA.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Tray)

Label for 0.75% Bupivacaine Hydrochloride Injection, USP, 75 mg/10 mL (7.5 mg/mL) single-dose teartop vial. The product is preservative-free and intended for epidural and retrobulbar anesthesia, with a warning stating it is not for obstetric or spinal anesthesia. Distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Label)

Label for Bupivacaine Hydrochloride Injection, USP 0.75% (7.5 mg/mL) in a 10 mL single-dose teartop vial by Hospira, Inc. The label notes preservative-free formulation, is Rx only, and includes NDC codes 0409-1165-01 and 0409-1165-18. Usage is designated for epidural and retrobulbar anesthesia, with a caution against obstetric or spinal anesthesia. The label also provides storage instructions and manufacturer details.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Tray)

Label of Bupivacaine Hydrochloride Injection USP 0.75%, 225 mg/30 mL (7.5 mg/mL) in a 30 mL single-dose teartop vial. The preservative-free solution is indicated for epidural and retrobulbar anesthesia and is not for obstetric or spinal anesthesia. Distributed by Hospira, Inc., Lake Forest, IL. The label includes NDC 0409-1165-19, lot and expiration date placeholders, and storage instructions.*

FDA Label Image

Principal Display Panel (75 mg/10 mL Vial Label)

Label for Bupivacaine Hydrochloride Injection USP 0.75% (7.5 mg/mL), packaged in a 30 mL single-dose teartop vial with a total of 225 mg per vial. The label specifies preservative-free solution, intended for epidural and retrobulbar anesthesia but not for obstetric or spinal anesthesia. It is distributed by Hospira, Inc., with manufacturing details indicating origin from Switzerland.*

FDA Label Image

Principal Display Panel (75 mg/10 mL Vial Tray)

Label for BUPIVACAINE HYDROCHLORIDE and epinephrine injection, 0.25% Bupivacaine HCl with 1:200,000 epinephrine, at 75 mg/30 mL (2.5 mg/mL) strength. The label states it is a 30 mL single-dose teartop vial for infiltration, nerve block, caudal and epidural anesthesia. Manufactured and distributed by Hospira, Inc. Additional cautionary and storage information is included.*

FDA Label Image

Label Ndc 0409-5757-18 (Bupivacaine 29)

Label for Bupivacaine Hydrochloride 0.25% (2.5 mg/mL) and epinephrine injection, 75 mg/30 mL vial, in a 30 mL single-dose teartop vial. The label indicates the product is sterile, nonpyrogenic, and intended for infiltration, nerve block, caudal, and epidural anesthesia. The labeler is Hospira, Inc.*

FDA Label Image

Bupivacaine 30

Label for Bupivacaine Hydrochloride and Epinephrine Injection, USP, 0.5% strength (5 mg/mL) in a 30 mL single-dose vial. The label states 150 mg/30 mL with epinephrine at 1:200,000 concentration. It includes storage instructions, warnings about sulfites, and the distributor Hospira, Inc. in Lake Forest, IL. The label also mentions it is Rx only and contains detailed ingredient information and handling precautions.*

FDA Label Image

Bupivacaine 31

Packaging label for Bupivacaine Hydrochloride 0.5% (5 mg/mL) with epinephrine 1:200,000 injection in a 30 mL single-dose teartop vial. The label shows the strength as 150 mg/30 mL (5 mg/mL) and includes product details such as sterility, nonpyrogenic, Rx only, and NDC 0409-9045-17. Distributed by Hospira, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.